Suraj Kalia
Stock Analyst at Oppenheimer
(3.72)
# 769
Out of 4,945 analysts
81
Total ratings
46.38%
Success rate
9.48%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Perform | n/a | $40.12 | - | 1 | Jul 7, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $17.31 | +27.09% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $129.74 | +15.62% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $35.40 | +27.12% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $10.78 | +113.36% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $162.44 | -26.13% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $42.95 | -25.49% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $96.32 | -3.45% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $129.28 | +0.56% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $3.90 | +156.41% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 | $78.18 | +15.12% | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $6.80 | +91.18% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $106.77 | +26.44% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $284.72 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $12.38 | +142.33% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $2.32 | +8,520.69% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $73.66 | +31.69% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.32 | +10.58% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $1.41 | +219.15% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.88 | +751.06% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $477.08 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.45 | +26,838.78% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $84.58 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $4.50 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $24.45 | +309.00% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $79.96 | - | 5 | Sep 12, 2018 |
PROCEPT BioRobotics
Jul 7, 2025
Initiates: Perform
Price Target: n/a
Current: $40.12
Upside: -
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $17.31
Upside: +27.09%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $129.74
Upside: +15.62%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $35.40
Upside: +27.12%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $10.78
Upside: +113.36%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $162.44
Upside: -26.13%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $42.95
Upside: -25.49%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $96.32
Upside: -3.45%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $129.28
Upside: +0.56%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $3.90
Upside: +156.41%
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $78.18
Upside: +15.12%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $6.80
Upside: +91.18%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $106.77
Upside: +26.44%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $284.72
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $12.38
Upside: +142.33%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $2.32
Upside: +8,520.69%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $73.66
Upside: +31.69%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $25.32
Upside: +10.58%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $1.41
Upside: +219.15%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.88
Upside: +751.06%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $477.08
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.45
Upside: +26,838.78%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $84.58
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $4.50
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $24.45
Upside: +309.00%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $79.96
Upside: -